Skip to main content
Compare/P04.0 vs P04.1

P04.0 vs P04.1

P04.0 (Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery) compared with P04.1 (Newborn affected by other maternal medication), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).

Can these codes be reported together?

Yes, when both are documented. P04.0 carries an Excludes2 note covering P04.1: “newborn affected by other maternal medication (P04.1-)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

Yes, when both are documented. P04.1 carries an Excludes2 note covering P04.0: “maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

Side by side

P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryP04.1Newborn affected by other maternal medication
Billing statusBillableNon-billable header

Report instead: P04.11, P04.12, P04.13, P04.14, P04.15

ClassificationP00-P96 — Certain Conditions Originating in the Perinatal Period (P00-P96)P00-P96 — Certain Conditions Originating in the Perinatal Period (P00-P96)
DefinitionNewborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery is a billable ICD-10-CM diagnosis code (P04.0).Newborn affected by other maternal medication is a non-billable ICD-10-CM category code (P04.1).
Includes
nonteratogenic effects of substances transmitted via placenta
Newborn affected by reactions and intoxications from maternal opiates and tranquilizers administered for procedures during pregnancy or labor and delivery
nonteratogenic effects of substances transmitted via placenta
Code first
any current condition in newborn, if applicable
, if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1)
withdrawal symptoms from therapeutic use of drugs in newborn (P96.2)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources